Adagene Management
Management criteria checks 2/4
Adagene's CEO is Peizhi Luo, appointed in Nov 2011, has a tenure of 13.08 years. directly owns 3.25% of the company’s shares, worth €2.84M. The average tenure of the management team and the board of directors is 6.2 years and 3.1 years respectively.
Key information
Peizhi Luo
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 13.1yrs |
CEO ownership | 3.3% |
Management average tenure | 6.2yrs |
Board average tenure | 3.1yrs |
Recent management updates
Recent updates
CEO
Peizhi Luo (58 yo)
13.1yrs
Tenure
Dr. Peter P. Luo, PhD, also known as Peizhi, is the Founder of Adagene Inc. and serves as its Chief Executive Officer since November 2011 and Director since February 2018. He serves as President of R&D at...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co- Founder | 13.1yrs | no data | 3.25% € 2.8m | |
CFO & Director | 5.3yrs | no data | no data | |
Executive Director & Head of Human Resources | 5.2yrs | no data | no data | |
Chief Strategy Officer & Head of Regulatory Affairs | less than a year | no data | no data | |
Chief Manufacturing Officer | 4.2yrs | no data | no data | |
Senior Vice President of Bioinformatics & Information Technology | 13.1yrs | no data | no data | |
Senior VP & Head of Clinical Operations | 13.1yrs | no data | 0.094% € 82.3k | |
Senior Vice President of Early Drug Discovery | 9.2yrs | no data | no data | |
VP & Head of Business Development | 7.2yrs | no data | no data | |
Executive Vice President of Clinical Development | 3.2yrs | no data | no data | |
VP and Head of Clinical & Quantitative Pharmacology | no data | no data | no data |
6.2yrs
Average Tenure
55yo
Average Age
Experienced Management: 978's management team is seasoned and experienced (6.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co- Founder | 6.8yrs | no data | 3.25% € 2.8m | |
CFO & Director | 3.8yrs | no data | no data | |
Independent Director | 1.3yrs | no data | no data | |
Member of Scientific & Strategic Advisory Board | 3.3yrs | no data | no data | |
Member Scientific and Strategic Advisory Board | 3.3yrs | no data | no data | |
Independent Director | 1.7yrs | no data | no data | |
Independent Director | 2.1yrs | no data | no data | |
Member Scientific & Strategic Advisory Board | 2.9yrs | no data | no data | |
Director | 1.7yrs | no data | no data | |
Member of Scientific & Strategic Advisory Board | 1.8yrs | no data | no data | |
Independent Director | 3.8yrs | no data | no data | |
Member Scientific & Strategic Advisory Board | 3.3yrs | no data | no data |
3.1yrs
Average Tenure
65yo
Average Age
Experienced Board: 978's board of directors are considered experienced (3.1 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 00:55 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Adagene Inc. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Claire Wang | China Renaissance Securities |
Bing Zhao | China Renaissance Securities |
Ziyi Chen | Goldman Sachs |